Barriers and Facilitators of Adherence to Oral Anticancer Medications Among Women with Breast Cancer: A Qualitative Study

被引:5
|
作者
Onwusah, Deborah Obehi [1 ,5 ]
Ojewole, Elizabeth Bolanle [1 ]
Manyangadze, Tawanda [2 ,3 ]
Chimbari, Moses John [2 ,4 ]
机构
[1] Univ KwaZulu Natal, Coll Hlth Sci, Sch Hlth Sci, Discipline Pharmaceut Sci, Durban, South Africa
[2] Univ KwaZulu Natal, Coll Hlth Sci, Sch Nursing & Publ Hlth, Discipline Publ Hlth Med, Durban, South Africa
[3] Bindura Univ Sci Educ, Fac Sci & Engn, Sch Geosci Disaster & Dev, Geosci, Bindura, Zimbabwe
[4] Great Zimbabwe Univ, Sch Med & Hlth Sci, Dept Publ Hlth, Masvingo, Zimbabwe
[5] Univ KwaZulu Natal, Discipline Pharmaceut Sci, Sch Hlth Sci, Private Bag X54001, ZA-4000 Durban, South Africa
来源
PATIENT PREFERENCE AND ADHERENCE | 2023年 / 17卷
关键词
medication adherence; oral antineoplastic agents; breast cancer; women's experiences; ENDOCRINE THERAPY; HORMONAL-THERAPY; NONADHERENCE; PERSISTENCE; SURVIVORS; CHEMOTHERAPY; MANAGEMENT;
D O I
10.2147/PPA.S416843
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose: Despite the life-saving benefits of oral anticancer medications (OAMs) to women with breast cancer (BC), adherence remains suboptimal and, in many cases, not well documented. The study examined barriers and facilitators of adherence to OAMs among women receiving BC treatment in Nigeria.Patients and Methods: The study was framed within the World Health Organization (WHO) Multidimensional Model of Adherence. We conducted qualitative in-depth interviews of 16 purposively sampled women in two tertiary hospitals in Southern Nigeria. The interviews were audio-recorded and transcribed verbatim. The interview data were analyzed using the Framework Method.Results: The key barriers to OAM adherence mentioned were socioeconomic factors (high cost of medication) and therapy-related factors (medication side effects). The key facilitating mechanisms for adherence to OAMs mentioned included; (i) patient-related psychosocial factors such as self-encouragement and self-discipline in sticking to the prescription, taking the medication at a particular time each day, receiving practical support from family members; and (ii) healthcare team/system factors such as obtaining an adequate supply of the medication at the pharmacy.Conclusion: Barriers and facilitators to OAM adherence are multidimensional. The study findings highlight the potential benefit of a multifaceted intervention (such as patient education and monitoring or strategies promoting cost-containment and side effects management) to optimize adherence. Therefore, our findings may inform the designing and evaluating of context-specific adherence measures and multifaceted intervention strategies targeting key barriers and approaches that enable adherence to enhance patient outcomes.
引用
收藏
页码:2821 / 2839
页数:19
相关论文
共 50 条
  • [1] Adherence to Oral Anticancer Medications Among Women With Breast Cancer in Africa: A Scoping Review
    Onwusah, Deborah O.
    Ojewole, Elizabeth B.
    Chimbari, Moses J.
    JCO GLOBAL ONCOLOGY, 2023, 9
  • [2] Barriers and facilitators to breast cancer screening among high-risk women: a qualitative study
    Conley, Claire C.
    Anderson, Alaina
    Rodriguez, Jennifer D.
    Kang, Hannah
    Taylor, Emily P.
    Luck, Conor
    Rosas Torres, Jacqueline
    Cheraghi, Nora
    Newton, Noelle
    Niell, Bethany L.
    O'Neill, Suzanne C.
    Vadaparampil, Susan T.
    BREAST CANCER RESEARCH AND TREATMENT, 2025, 209 (01) : 61 - 71
  • [3] Barriers and facilitators of adjuvant hormone therapy adherence and persistence in women with breast cancer: a systematic review
    Moon, Zoe
    Moss-Morris, Rona
    Hunter, Myra S.
    Carlisle, Sophie
    Hughes, Lyndsay D.
    PATIENT PREFERENCE AND ADHERENCE, 2017, 11 : 305 - 322
  • [4] Understanding tamoxifen adherence in women with breast cancer: A qualitative study
    Moon, Zoe
    Moss-Morris, Rona
    Hunter, Myra S.
    Hughes, Lyndsay D.
    BRITISH JOURNAL OF HEALTH PSYCHOLOGY, 2017, 22 (04) : 978 - 997
  • [5] Barriers and facilitators to endocrine therapy adherence among underserved hormone-receptor-positive breast cancer survivors: a qualitative study
    Wells, Kristen J.
    Pan, Tonya M.
    Vazquez-Otero, Coralia
    Ung, Danielle
    Ustjanauskas, Amy E.
    Munoz, Dariana
    Laronga, Christine
    Roetzheim, Richard G.
    Goldenstein, Marissa
    Carrizosa, Claudia
    Nuhaily, Sumayah
    Johnson, Kenneth
    Norton, Marilyn
    Sims, Elizabeth
    Quinn, Gwendolyn P.
    SUPPORTIVE CARE IN CANCER, 2016, 24 (10) : 4123 - 4130
  • [6] Barriers and facilitators to endocrine therapy adherence among underserved hormone-receptor-positive breast cancer survivors: a qualitative study
    Kristen J. Wells
    Tonya M. Pan
    Coralia Vázquez-Otero
    Danielle Ung
    Amy E. Ustjanauskas
    Dariana Muñoz
    Christine Laronga
    Richard G. Roetzheim
    Marissa Goldenstein
    Claudia Carrizosa
    Sumayah Nuhaily
    Kenneth Johnson
    Marilyn Norton
    Elizabeth Sims
    Gwendolyn P. Quinn
    Supportive Care in Cancer, 2016, 24 : 4123 - 4130
  • [7] Adherence to Oral Administration of Endocrine Treatment in Patients With Breast Cancer: A Qualitative Study
    Iacorossi, Laura
    Gambalunga, Francesca
    Fabi, Alessandra
    Giannarelli, Diana
    Marchetti, Anna
    Piredda, Michela
    De Marinis, Maria Grazia
    CANCER NURSING, 2018, 41 (01) : E57 - E63
  • [8] Exploring the factors influencing adherence to oral anticancer drugs in patients with digestive cancer: a qualitative study
    Nizet, Pierre
    Touchefeu, Yann
    Pecout, Solange
    Cauchin, Estelle
    Beaudouin, Eva
    Mayol, Severine
    Fronteau, Clementine
    Huon, Jean-Francois
    SUPPORTIVE CARE IN CANCER, 2022, 30 (03) : 2591 - 2604
  • [9] Adherence to oral hormonal anticancer agents in breast cancer
    Gori, Stefania
    Modena, Alessandra
    Foglietta, Jennifer
    Verze, Matteo
    Inno, Alessandro
    Casarin, Alessandra
    Russo, Antonio
    Nicolis, Fabrizio
    TUMORI JOURNAL, 2023, 109 (03): : 262 - 268
  • [10] Barriers to and facilitative processes of endocrine therapy adherence among women with breast cancer
    Bright, Emma E.
    Petrie, Keith J.
    Partridge, Ann H.
    Stanton, Annette L.
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 158 (02) : 243 - 251